baber/WOPTO huggingface dataset:
Patent NZ-591180-A (NZ)
Title: Improved synthesis of hexahydrodibenzopyranones such as nabilone
Inventor: MIKAYLO VALERIY
IPC: C07D311/80
Filed: 2009-08-28
Abstract: Disclosed a process for preparing a 6a,10a-cis-hexahydrodibenzo[b,d]pyran-9-one such as cis-nabilone, and as represented by the general formula (I): wherein R1 is alkyl, alkenyl, cycloalkyl, or cycloalkenyl, and wherein the hydrogen atoms at the 6a and 10a positions are oriented cis to one another, comprising the step of: (ii) reacting a 5-substituted resorcinol of the formula (II), with a 1-alkoxy-4-(1-hydroxy-1-methylethyl)-1,4-cyclohexadiene of the formula (III), wherein R2 is alkyl, in the presence of (a) a Lewis acid selected from trifluoromethanesulfonic anhydride (Tf2O), trifluoromethanesulfonic acid (TfOH), or sulfuric acid, and (b) an organic solvent.
Patent NZ-591673-A (NZ)
Title: A bench scale pressure reactor unit with data acquisition and control system for chemical leaching of minerals
Inventor: DASH P S
IPC: C22B3/02
Filed: 2009-05-11
Abstract: Disclosed is a bench-scale pressure reactor system for extracting minerals and metals through a chemical leaching process at elevated temperature and pressure, comprising :- a batch reactor (1) having means for heating and continuous mixing of metals or minerals, the reactor (1) comprising a charging funnel (2) with a first valve (Vl) for discharging feed materials inside the reactor (1);- a gas pressure application means (3, V2) for applying pressure inside the reactor (1) by adapting one of air nitrogen and argon, the means (3) comprising perforations and having side arms (4) with perforations thereon, each arm (4) disposed at different angles inside the reactor (1);- a pressure sensor (6) including a pressure controller (V4) disposed inside the reactor (1), and a resistance temperature detector (16) mounted on the reactor (1), the resistance temperature detector (16) being connected to one each PID-controller (17, 18) allocated for control of pressure and temperature inside the reactor (1); - a chiller unit (5) fillable with ice or cold water, and having one each horizontal and vertical coil (5a, 5b) provided to the reactor (1), the vertical coil (5b) and the horizontal coil (5a) being respectively connected to the pressure controller (V4) and a pressure transmitter (7) via condenser (8);- a third valve (V3) for taking out the products on completion of the reaction time in the reactor (1);- a sensor (9) to determine the amount of current passing through the heating means of the reactor (1);- a data acquisitions means (11) connected to a host computer (10) for collecting, processing and outputting the on-line data for monitoring and control of the chemical leaching process; and- analyzing means to analyze the slurry and filtrate produced during the process implementation.
Patent NZ-595052-A (NZ)
Title: A method of processing digital evidence on a clustered file system
Inventor: AYERS DANIEL FRANCIS
IPC: G06F19/00
Filed: 2010-11-17
Abstract: A system and method of processing digital evidence is disclosed. The method comprises the steps of: (a) constructing a hierarchy of pre-compiled processing modules that specify processing steps; (b) receiving input digital data; (c) processing the digital data using the processing steps to obtain processing results; (d) dynamically modifying the hierarchy and/or execution of the pre-compiled processing modules based on one or more of the input digital data, processing module inputs, and events in a digital evidence processing system performing the method; (e) logging details of use of each processing module; and (f) writing the processing results on a data storage device.
Patent NZ-598210-A (NZ)
Title: AHAS mutants
Inventor: MCELVER JOHN A
IPC: A01H5/00
Filed: 2008-04-03
Abstract: Patent No. 598210 Disclosed is an isolated, recombinant mutagenized or synthetic polypeptide encoding an acetohydroxyacid synthase large subunit (AHASL) polypeptide having a valine, glutamine, cysteine, or methionine substitution at a position corresponding to position 122 of Arabidopsis thaliana AHASL or position 90 of Zea mays AHASL number two.
Patent NZ-603574-A (NZ)
Title: Pesticidal composition, and method for controlling pests
Inventor: AWAZU TAKAO
IPC: A01N25/30
Filed: 2009-04-10
Abstract: 603574 Disclosed is a pesticidal composition comprising N-cyanomethy1-4-trifluoromethy1-3-pyridinecarboxyamide (flonciamid) or its salt and at least one potency-enhancing component selected from an alkylbenzene sulfonic acid, an a-olefin sulfonic acid, a polyoxyethylenealkylphenyl ether sulfonic acid, a polyoxyethylenealkyl ether sulfosuccinic acid half ester, a naphthalene sulfonic acid, a dodecylbenzene sulfonic acid diethanolamine salt, or salts thereof. Also disclosed is a method for enhancing the pesticidal potency of N-cyanomethy1-4- trifluoromethy1-3-pyridinecarboxyamide or its salt by combining it with at least one potency-enhancing component selected from a dialkylsulfosuccinic acid salt, a dialkylsulfosuccinic acid, an alkylbenzene sulfonic acid, an a-olefin sulfonic acid, apolyoxyethylenealkylphenyl ether sulfonic acid, a polyoxyethylenealkyl ether sulfosuccinic acid half ester, a naphthalene sulfonic acid, an alkylnaphthalene sulfonic acid, a dodecylbenzene sulfonic acid diethanolamine salt, or salts thereof.
Patent NZ-610526-A (NZ)
Title: Deuterium enriched rasagiline
Inventor: BAHAR ELIEZER
IPC: C07C211/42
Filed: 2011-10-25
Abstract: Provided are deuterium enriched pharmaceutical compositions comprising deuterium enriched rasagiline compounds, where R1, R2 and R3 are independently hydrogen or deuterium, and a pharmaceutically acceptable carrier. The compounds may be used for treating neurodegenerative disorders, particularly Parkinson’s disease.
Patent NZ-612593-A (NZ)
Title: Use of a vegf antagonist to treat angiogenic eye disorders
Inventor: YANCOPOULOS GEORGE D
IPC: A61P27/00
Filed: 2012-01-11
Abstract: Disclosed herein are methods for treating angiogenic eye disorders by sequentially administering multiple doses of a VEGF antagonist to a patient. The methods of the present invention include the administration of multiple doses of a VEGF antagonist to a patient at a frequency of once every 8 or more weeks. The methods disclosed herein are useful for the treatment of angiogenic eye disorders such as age related macular degeneration, diabetic retinopathy, diabetic macular edema, central retinal vein occlusion and corneal neovascularization.
Patent NZ-615497-A (NZ)
Title: Vacuuming device comprising a vacuum cleaner and a bag filter
Inventor: SCHULTINK JAN
IPC: A47L9/28
Filed: 2012-03-20
Abstract: Disclosed is a vacuuming device with improved airflow and efficiency. The device which comprises a vacuum cleaner and a bag filter and in which the vacuum cleaner has a rated input power of less than 1200 W, preferably less than 1100 W, especially preferably less than 900 W, the vacuum cleaner has a motor-fan unit and a regulation device that regulates the vacuum cleaner in such a way that the air flow is kept essentially constant at a minimum value of 34 l/s, preferably essentially constant at a minimum value of 37 l/s, especially preferably essentially constant at a minimum value of 40 l/s when the bag filter is loaded with DMT8 test dust according to EN 60312, and the bag filter is a disposable filter that is made of nonwoven fabric and has a drop in air flow of less than 15 percent, preferably less than 10 percent, especially preferably less than 5 percent when testing the reduction in maximum air flow with a partly filled dust receptacle according to EN 60312.
Patent NZ-618300-A (NZ)
Title: Methods of treating or preventing cholesterol related disorders
Inventor: CHAN JOYCE CHI YEE
IPC: C07K16/40
Filed: 2012-05-10
Abstract: Disclosed is a stable formulation comprising at least one monoclonal antibody that specifically binds to PCSK9 or a fragment of said monoclonal antibody that specifically binds to PCSK9, wherein PCSK9 comprises the amino acids of SEQ ID NO 1, said monoclonal antibody or said fragment in an amount of about 40 mg/ml to about 300 mg/ml, and a pharmaceutically acceptable buffer in an amount of about 0.05 mM to about 40 mM, and a pharmaceutically acceptable surfactant in an amount of about 0.04% w/v to about 20% w/v, and at least one pharmaceutically acceptable stabilizer in an amount of about 0.5% w/v to about 10% w/v, wherein the stable formulation has a pH of between about 4.0 to about 6.0.
Patent NZ-627622-A (NZ)
Title: A method for upgrading a gas
Inventor: WENNERGREN BO
IPC: C01B32/50
Filed: 2013-01-02
Abstract: The disclosure relates to a method for upgrading a gas by separation of carbon dioxide therefrom, which method comprises the steps of introducing a stream of gas to a wet bed of weakly basis ion exchange resin provided with tertiary amine groups, and desorbing the adsorbed carbon dioxide from the resin by increasing the temperature and/or lowering the pressure in said wet bed.
Patent NZ-629180-A (NZ)
Title: Tap changer
Inventor: REICH ALEXANDER
IPC: H02P13/06
Filed: 2013-01-15
Abstract: The invention relates to a tap changer for voltage regulation with semiconductor switching components (S1.1, S1.2; S1.3, S1.4; S2.1, S2.2; S2.3, S2.4; S3.1, S3.2; S3.3, S3.4; S4.1, S4.2; S4.3, S4.4) on a regulating transformer having a regulating winding. The tap changer is of a modular design and each module (M1, M2, M3) comprises, respectively, one partial winding of the regulating winding, which is connectible or disconnectible by means of semiconductor switching components(S1.1, S1.2; S1.3, S1.4; S2.1, S2.2; S2.3, S2.4; S3.1, S3.2; S3.3, S3.4; S4.1, S4.2; S4.3, S4.4). Varistors (R1.1, R1.2; R1.3, R1.4; R2.1, R2.2; R2.3, R2.4; R3.1, R3.2; R3.3, R3.4; R4.1, R4.2; R4.3, R4.4) and capacitors (C1.1, C1.2; C1.3, C1.4; C2.1, C2.2; C2.3, C2.4; C3.1, C3.2; C3.3, C3.4; C4.1, C4.2; C4.3, C4.4) are additionally integrated for protecting the semiconductor switching components (S1.1, S1.2; S1.3, S1.4; S2.1, S2.2; S2.3, S2.4; S3.1, S3.2; S3.3, S3.4; S4.1, S4.2; S4.3, S4.4) against high voltages.
Patent NZ-705178-A (NZ)
Title: Anti-prolactin receptor antibody formulations
Inventor: NIU JIANJIE
IPC: C07K16/28
Filed: 2013-08-28
Abstract: Provided are a wide concentration range, especially high concentration, substantially salt-free anti-prolactin receptor antibody formulations that are substantially isosmotic and of low viscosity. In particular, a preferred embodiment includes: an anti-PRLR antibody formulation, comprising: a. 10 mM histidine, b. 75 ppm or 80 ppm polysorbate 80, c. 205 mM to 292 mM sucrose or trehalose, d. 10 mM to 50 mM arginine, e. 5 mM or 10 mM methionine, and f. 1 mg/ml to 60 mg/ml of an anti-PRLR antibody, wherein said anti-PRLR antibody formulation has a pH ranging from pH 5.0 to pH 6.5, wherein said anti-PRLR antibody formulation contains no inorganic salt and wherein said anti-PRLR antibody is a human IgG2 monoclonal antibody which comprises a heavy chain and a light chain, wherein the amino acid sequence of said heavy chain is according to SEQ ID NO: 7, and the amino acid sequence of said light chain is according to SEQ ID NO: 1.
Patent NZ-709324-A (NZ)
Title: Food processing apparatus and method
Inventor: Antonio hu
IPC: A47J44/02
Filed: 2015-06-19
Abstract: Food processors such as blenders use a drive unit to spin one or more blades to process food. Many food processors have a drive unit that supports a food processing container. In accordance with the present invention, there is described a food processing apparatuses having a drive unit which has more than one mode of operation, works with more than one food processing container, and/or may be operated in more than orientation are disclosed. The drive unit may be operated in first and second modes of operation. In some embodiments, the drive unit may be actuated in a different manner in the second mode of operation as compared to the first mode of operation. In some embodiments, the orientation of the drive unit in the second mode of operation is vertically flipped upside-down as compared to the orientation of the drive unit in the first mode of operation.
Patent NZ-711564-A (NZ)
Title: Methods of treating colorectal cancer
Inventor: MONTELEONE GIOVANNI
IPC: C12N15/113
Filed: 2014-03-14
Abstract: Disclosed herein are methods for treating/and or preventing colorectal cancer using a specific inhibitor of SMAD7 expression or function. Also disclosed are pharmaceutical compositions containing an inhibitor of SMAD7 for treating and/or preventing colorectal cancer and manufacture of medicaments containing an inhibitor of SMAD7 to be used in treating and/or preventing colorectal cancer.
Patent NZ-712391-A (NZ)
Title: Uridine nucleoside derivatives, compositions and methods of use
Inventor: HAYDON PHILIP
IPC: A61P37/00
Filed: 2014-03-13
Abstract: This disclosure relates to uridine nucleoside derivatives of formula I, compositions comprising therapeutically effective amounts of those nucleoside derivatives and methods of using those nucleoside derivatives or compositions in treating disorders that are responsive to ligands, such as agonists, of P2Y6 receptor, e.g., neuronal disorders, including neurodegenerative disorders (e.g., Alzheimer’s disease, Parkinson’s disease) and traumatic CNS injury, pain, Down Syndrome (DS), glaucoma and inflammatory conditions.
Patent NZ-713672-A (NZ)
Title: Eddy current brake configurations
Inventor: ALLINGTON CHRISTOPHER JAMES
IPC: F16D63/00
Filed: 2014-12-04
Abstract: Described herein are eddy current brake and methods of use, particularly configurations that have a kinematic relationship with exactly two rotational degrees of freedom about a first primary axis of rotation and a secondary control axis, respectively, and zero linear degrees of freedom, wherein the first primary axis is orthogonal to the secondary control axis of rotation, and wherein, during operation, braking action is applied to the primary axis and the secondary control axis is used to modulate the braking action; wherein the first primary axis and the secondary control axis of rotation intersect.
Patent NZ-714938-A (NZ)
Title: A method for saccharifying paper feedstock
Inventor: MEDOFF MARSHALL
IPC: D21H25/18
Filed: 2012-02-14
Abstract: Disclosed is a method of saccharifying a paper feedstock (such as magazines, coated paper, and poly-coated paper), the method comprising: providing in a vessel, a mixture comprising a paper feedstock, water, a food-based nutrient source, and an enzyme complex; and using jet mixing to mix the vessel contents, while saccharifying at least a portion of the paper feedstock to produce saccharified biomass comprising one or more sugars; wherein the initial paper feedstock comprises paper having a pigment, filler, and/or coating content of at least 10 weight percent; and wherein the process includes a treatment step before, during or after saccharification step to remove the pigment, filler and/or coating. The process may also include an additional step of exposing the paper feedstock to irradiation, the irradiation provided by one or more of: an ion beam and an electron beam.
Patent NZ-727214-A (NZ)
Title: Substituted chromene derivatives as selective dual inhibitors of pi3 delta and gamma protein kinases
Inventor: VAKKALANKA SWAROOP KUMAR VENKATA SATYA
IPC: C07D487/04
Filed: 2015-06-26
Abstract: The present invention relates to a selective dual delta (δ) and gamma (γ) PI3K protein kinase modulator (S)-N-(5-(4-amino-1-(1-(5-fluoro-3-(3-fluorophenyl)-4-oxo-4H- chromen-2-yl)ethyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-2-methoxyphenyl) methane sulfonamide, methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of PI3K kinase mediated diseases or disorders with them.
Patent NZ-734666-A (NZ)
Title: System, method and computer program for an access control system
Inventor: KARAM ANTHONY
IPC: G07B15/04
Filed: 2016-01-12
Abstract: A system, method, mobile communication device and one or more computer programs for an access control system for controlling access to a restricted area. In one form, the restricted area is a parking station. In one aspect, the system includes: a communication system; and a computer program executable by a mobile communication device configured to: receive one or more entry signals from the communication system when the entity approaches an entry point of a restricted area; transfer, to the communication system, an entry request; receive, from the communication system, authorisation data indicative of the entity being granted access to enter the restricted area by an access control system; receive one or more exit signals from the communication system when the entity approaches an exit point of the restricted area; and transfer, to the communication system, an exit request indicative of the authorisation data in order to exit the restricted area.
Patent NZ-740605-A (NZ)
Title: Double-glazed window assembly and retrofit method of forming same
Inventor: NOWAKOWSKI KAZIMIERZ THOMAS
IPC: E06B3/28
Filed: 2016-08-12
Abstract: There is disclosed a double-glazed window assembly comprising: a pre-existing window installed in a window cavity; and a retrofitted assembly which comprises: window panelling; a frame fixed around the cavity (“the fixed frame”); and a frame to which the panelling is applied (“the panelling frame”), the panelling frame comprising frame members having a coefficient of thermal expansion the same as or similar to that of the window panelling, whereby it is configured to expand and contract with the panelling under changes in temperature of the panelling, and being mounted to the fixed frame, wherein said frame members comprise peripheral frame members, extending around a periphery of the panelling, each peripheral frame member being slidably engaged with the fixed frame so as to move axially relative thereto when expanding and contracting. The members thus, advantageously, function as a frame for the panelling without constraining the panelling against expansion or contraction – whereby a proneness of the panelling to warping or becoming decoupled is eliminated.
Patent NZ-748133-A (NZ)
Title: Agents for treatment of claudin expressing cancer diseases
Inventor: SAHIN UGUR
IPC: C07K16/30
Filed: 2013-11-12
Abstract: The present inventon provides bispecific binding agents that contain a binding domain that is specific for CD3 allowing binding to T cells and a binding domain that is specific for claudin6, and methods of using these binding agents or nucleic acids encoding therefor for treatng cancer.
Patent NZ-750476-A (NZ)
Title: Securement device for an orthopedic prosthesis, thermal treatment device for an orthopedic prosthesis, and methods of use
Inventor: TERMANINI ZAFER
IPC: A61F2/46
Filed: 2017-08-11
Abstract: The present invention relates generally to devices and methods for firmly joining together components of a modular orthopedic prosthesis by securing female to male parts thereof together, and in particular a male part present in a modular component into a correspondingly configured female part (i.e., bore or recess) present in a further modular component thereof. Prior art devices and techniques suffer from problems such as metal wear debris entering the patient, micromotion in the join causing “fretting corrosion” all which can cause damage to interfacial contact surfaces. The present invention seeks to go some way to overcoming such problems of the prior art by providing an orthopedic device assembly adapted for removably retaining a heated component of an orthopedic prosthesis which is heated by a heating device, the heated component having a tapered cavity configured for the receipt of a correspondingly configured male part of an orthopedic device, the orthopedic device assembly comprising: an upper metallic handle shaft, a lower cylindrical impactor body having a round bottom and which includes a spring loaded retaining lever having a claw adapted to hold the heated component within a cylinder of the lower cylindrical impactor body and which retains the heated component within the lower cylindrical impactor body until the spring associated with the spring loaded retaining lever is compressed and the claw disengages the heated component, the lower cylindrical impactor body affixed to said handle shaft configured to removably hold the heated component having a temperature of at least 138°C, the heated component having the tapered cavity, and a protective circular thermal skirt adapted to keep surrounding tissues away from and insulated from the heated component retained within the protective circular thermal skirt.
Patent NZ-754706-A (NZ)
Title: Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus
Inventor: WICKENS KRISTIN LEE
IPC: A61P3/10
Filed: 2017-06-02
Abstract: The present invention provides methods of treating or preventing gestational diabetes by administering Lactobacillus rhamnosusHN001 or derivatives thereof, in addition to uses, compositions, and medicaments comprising Lactobacillus rhamnosusHN001 or derivatives thereof to treat or prevent gestational diabetes mellitus.
Patent NZ-755273-A (NZ)
Title: Virtual and augmented reality systems and methods
Inventor: SCHOWENGERDT BRIAN
IPC: H04J14/00
Filed: 2014-11-27
Abstract: Disclosed is a system for displaying content to a user. The system includes a light source configured to project light associated with at least first and second frames of image data and a waveguide assembly configured to relay the projected light towards at least one eye of a user with a wavefront curvature for a focus level corresponding to a focal distance for the respective first or second frame of image data. The waveguide assembly comprises a first waveguide component operatively coupled to a first weak lens to modify first light associated with the first frame of image data such that the first light is perceived as coming from a first focal plane and a second waveguide component. The first waveguide component and the second waveguide component sandwich the first weak lens and are stacked along a z-axis in front of the at least one eye of the user.
Patent NZ-760917-A (NZ)
Title: Method and system for deciding damage degree category
Inventor: TESHIGAWARA MASAOMI
IPC: G01M99/00
Filed: 2018-07-06
Abstract: [[Problem] A method for evaluating damage degree and a system for implementing the same are provided. [Solution] A polygonal line including a first break point P1, a second break point P2, and a maximum response point Pm is determined from a performance curve of each layer of a building. A maximum interlayer deformation angle of each layer is calculated from a maximum interlayer displacement of each layer and its corresponding interlayer height. A safety margin of each layer is calculated from the maximum interlayer deformation angle and a safety limit deformation angle, safety margins are compared, and one polygonal line having the smallest safety margin is selected. A safety limit point Ps is calculated using the polygonal line selected. Damage degree categories (I) to (VI) are defined using the first break point P1, the second break point P2, and the safety limit point Ps. One damage degree category, to which the maximum response point Pm corresponds, is decided out of the damage degree categories (I) to (VI).
Patent NZ-797161-A (NZ)
Title: Crystalline form of l-glufosinate ammonium salt and process for production thereof
Inventor: KINI PRASHANT VASANT
IPC: A01N25/12
Filed: 2021-07-30
Abstract: The present disclosure relates to a novel crystalline form of L-glufosinate ammonium salt and a process for preparation thereof. The present disclosure also provides compositions comprising said form and a method for the control of undesired plant growth using said compositions.